Dutasteride 2.5 mg Progress (6 months)
    4/9/2026

    From the encyclopedia
    Dutasteride β†’

    Heavy duty finasteride that comes with higher risks

    Minoxidil β†’

    An essential vasodilator with some anti-androgenic effects

    Finasteride β†’

    Frontline, gold standard treatment for combatting androgenic alopecia

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    πŸ’Š Dutasteride (oral) 2.5 mg daily 6 months
    πŸ’Š Minoxidil (oral) 5 mg daily 6 months
    πŸ’Š Finasteride (oral) 1 mg daily 4.5 years
    the tone is πŸ˜€ positive with total regrowth results.

    Other terms

    A 49-year-old male switched from Finasteride to Dutasteride 2.5 mg daily, along with oral Minoxidil 5 mg, resulting in significant hair regrowth and stopping hair loss after six months. Despite initial side effects like adrenaline spikes and urinary issues, the user is satisfied with the results and plans to continue the treatment.
    View this post in the Community β†’

    Similar Community Posts Join

    6 / 6 results

    Related Research

    6 / 6 results
      Medical Management Options for Hair Loss

      research Medical Management Options for Hair Loss

      July 2011 in “Springer eBooks”
      This review discusses both conventional and new pharmaceutical treatments for hair loss, as well as various natural and herbal remedies, but reports no new clinical results.
      Nonsurgical Therapy for Hair Loss

      research Nonsurgical Therapy for Hair Loss

      14 citations , August 2013 in “Facial Plastic Surgery Clinics of North America”
      This review discusses current and emerging medical therapies for androgenetic alopecia but reports no new clinical findings, emphasizing the importance of stabilizing the condition as a complement to surgical hair restoration.
      Androgens and Hair Loss: An In-Depth Analysis of Androgenetic Alopecia

      research Androgens and hair loss

      52 citations , June 2009 in “Current Opinion in Endocrinology, Diabetes and Obesity”
      This review discusses the pathogenesis and treatment of androgenetic alopecia, highlighting genome associations and newer topical formulations, but reports no new clinical results.
      Finasteride in Androgenetic Alopecia in Men

      research Finasteride in androgenetic alopecia in men

      June 2007 in “Advances in Dermatology and Allergology/PostΔ™py Dermatologii i Alergologii”
      This article discusses androgenetic alopecia in men and reports that finasteride at 1 mg/day for 24 months is generally well tolerated and may effectively inhibit hair loss.
      Female Pattern Alopecia: Current Perspectives

      research Female pattern alopecia: current perspectives

      42 citations , August 2013 in “International Journal of Women's Health”
      This review discusses the current therapeutic options for female pattern hair loss and emphasizes the need for managing patient expectations of permanent regrowth, reporting no new clinical results.